Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTDSPL | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
mRNA | GPX1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
mRNA | NLRP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | OSBPL5 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | CECR6 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | PTPRE | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | GRAMD4 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |